Neuralink has started human chip trials: mass production planned for 2026

Neuralink's Plans for the Future

According to Главком: Neuralink, founded by Elon Musk, has announced plans for mass production of its brain-computer interface devices starting in 2026. By 2024, Neuralink began clinical trials on humans, marking an important step in the development of the technology. This initiative aims to implant chips into 20,000 people annually.

Technological Achievements and Challenges

The technology for implanting threads into the brain was introduced by Neuralink in the summer of 2019. However, in 2022, the U.S. Food and Drug Administration rejected the company's application, raising questions about the project's future development. Despite this, Neuralink continues to work on its technologies and already has experience with its first patient who used the chip for playing video games, browsing the internet, posting on social media, and moving the cursor on a laptop.

The company aims to achieve annual revenue of over one billion dollars by 2031, indicating Neuralink's ambitious plans in the field of neurotechnology. Human trials could become a crucial step for the commercial implementation of these technologies and change the way people interact with computers.

The development of Neuralink's technologies could significantly impact the medical field, particularly in treating neurological diseases and restoring functions in patients. The success of clinical trials might open new horizons for integrating the human brain with digital technologies, which in turn could change traditional approaches to treatment and rehabilitation. It is essential to monitor the company's further steps and the response of regulatory bodies to its achievements.